Susan O’Brien - Concepedia

Concepedia

Author

Susan O’Brien

The University of Texas MD Anderson Cancer Center

Also Known As

O’Brien Susan, Susan O'Brien, Susan O’Brien

30

Publications

2.9K

Citations

17

H-Index

23

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The Ohio State University Leukemia Research Foundation

SO

About

Susan O’Brien is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	761
2	Health Sciences	3	3	215
3	Immunology	2	2	490
4	Blood Transplantation	1	1	80
5	Cell Biology	1	1	12

Susan O’Brien

×

18

Publications

2.9K

Citations

16

H-Index

	Year	Citations
Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia William G. Wierda, Susan O’Brien, Sijin Wen, Journal of Clinical Oncology	2005	521
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia Sherif Ibrahim, Michael J. Keating, Kim‐Anh Do, Blood	2001	449
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study Hagop M. Kantarjian, Deborah A. Thomas, Jeffrey L. Jorgensen, The Lancet Oncology Inotuzumab OzogamicinLymphoid NeoplasiaHematological MalignancyMedicineAnti-cd22–calecheamicin Conjugate	2012	410
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience Susan O’Brien, Richard R. Furman, Steven Coutré, Blood	2018	368
Chronic Myelogenous Leukemia Susan O’Brien, Ellin Berman, Hossein Borghaei, Journal of the National Comprehensive Cancer Network	2009	209
Primary refractory and relapsed adult acute lymphoblastic leukemia Deborah A. Thomas, Hagop M. Kantarjian, Terry L. Smith, Cancer	1999	196
Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse Farhad Ravandi, Hagop M. Kantarjian, Stefan Faderl, Leukemia Research Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematology	2009	124
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis Paul M. Derderian, H. Kantarjian, Moshe Talpaz, The American Journal of Medicine Hematological MalignancyLymphoid NeoplasiaMedicineMixed-phenotype Acute LeukemiaLymphoid Blastic Phase	1993	111
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia Hagop M. Kantarjian, Moshe Talpaz, Terry L. Smith, Journal of Clinical Oncology	2000	93
Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes Partow Kebriaei, Rima M. Saliba, Gabriela Rondón, Biology of Blood and Marrow Transplantation First RemissionMixed-phenotype Acute LeukemiaImmunologyImmunotherapyMyeloid Neoplasia	2011	80

Page 1